Chemed (NYSE:CHE) Hits New 52-Week High Following Dividend Announcement

Shares of Chemed Corporation (NYSE:CHE) reached a new 52-week high on Thursday following a dividend announcement from the company. The stock traded as high as $551.74 and last traded at $544.6710, with a volume of 9304 shares traded. The stock had previously closed at $546.51.

The newly announced dividend which will be paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th will be given a dividend of $0.70 per share. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, August 17th. Chemed’s payout ratio is currently 12.05%.

Analyst Ratings Changes

CHE has been the topic of a number of analyst reports. Oppenheimer increased their price objective on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Royal Bank Of Canada increased their price objective on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a report on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Price Performance

The company has a market capitalization of $7.22 billion, a P/E ratio of 27.74, a P/E/G ratio of 2.08 and a beta of 0.51. The business’s 50-day simple moving average is $477.97 and its 200 day simple moving average is $439.84. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. During the same period last year, the firm posted $4.27 earnings per share. The business’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, sell-side analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Patrick P. Grace sold 190 shares of the firm’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the transaction, the director directly owned 3,533 shares of the company’s stock, valued at $1,879,556. This represents a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 3,537 shares of company stock valued at $1,782,654. 3.33% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Chemed

Hedge funds and other institutional investors have recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. boosted its holdings in Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after buying an additional 5,549,876 shares in the last quarter. BlackRock Inc. bought a new position in shares of Chemed in the second quarter valued at $691,290,000. Norges Bank acquired a new stake in shares of Chemed during the 4th quarter valued at $76,067,000. AQR Capital Management LLC lifted its position in shares of Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after acquiring an additional 153,469 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Chemed by 1,260.2% during the 4th quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock worth $50,353,000 after acquiring an additional 109,033 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.